MIMIX™ smart-release therapies mimic infections, but without all the side effects. They are administered over time in the skin (an immunologic organ) to stimulate a more powerful and durable immune response to fight diseases ranging from influenza to cancer.
Quick, simple, and painless, Vaxess is redefining accessible health care with exceptionally effective MIMIX™ vaccines. We are making a more efficacious flu vaccine and partnering to develop a SARS-CoV-2 vaccine that enables global distribution.Learn More
MIMIX™ relies on strong, stable, and biocompatible, silk fibroin—an essential structural protein in silk—to protect unstable target molecules during sustained release at body temperature. At Vaxess, we can tune the characteristics of silk fibroin to provide the most effective qualities for medicine and vaccine delivery.Discover Silk PUBLICATIONS